Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Am J Hematol. 2017 Feb 3;92(3):238–243. doi: 10.1002/ajh.24625

Figure 1. Outcomes for patients based on additional chromosomal abnormalities.

Figure 1

Relapse-free survival (A) and overall survival (B) for patients with and without poor-risk additional chromosomal abnormalities at diagnosis.